Carcinoma, Pancreatic Ductal

"Carcinoma, Pancreatic Ductal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS.

Descriptor ID	D021441
MeSH Number(s)	C04.557.470.200.025.232.750 C04.557.470.615.132.750 C04.588.274.761.750 C04.588.322.475.750 C06.301.761.750 C06.689.667.625 C19.344.421.750
Concept/Terms	Carcinoma, Pancreatic Ductal Carcinoma, Pancreatic Ductal Carcinomas, Pancreatic Ductal Ductal Carcinoma, Pancreatic Ductal Carcinomas, Pancreatic Pancreatic Ductal Carcinomas Duct-Cell Carcinoma of the Pancreas Duct Cell Carcinoma of the Pancreas Pancreatic Ductal Carcinoma Ductal Carcinoma of the Pancreas Pancreatic Duct Cell Carcinoma Carcinoma, Ductal, Pancreatic Duct-Cell Carcinoma, Pancreas Carcinoma, Pancreas Duct-Cell Carcinomas, Pancreas Duct-Cell Duct Cell Carcinoma, Pancreas Duct-Cell Carcinomas, Pancreas Pancreas Duct-Cell Carcinoma Pancreas Duct-Cell Carcinomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Pancreatic Ductal".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Ductal [C04.557.470.200.025.232]
Carcinoma, Pancreatic Ductal [C04.557.470.200.025.232.750]
Neoplasms, Ductal, Lobular, and Medullary [C04.557.470.615]
Carcinoma, Ductal [C04.557.470.615.132]
Carcinoma, Pancreatic Ductal [C04.557.470.615.132.750]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Pancreatic Neoplasms [C04.588.274.761]
Carcinoma, Pancreatic Ductal [C04.588.274.761.750]
Endocrine Gland Neoplasms [C04.588.322]
Pancreatic Neoplasms [C04.588.322.475]
Carcinoma, Pancreatic Ductal [C04.588.322.475.750]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Pancreatic Neoplasms [C06.301.761]
Carcinoma, Pancreatic Ductal [C06.301.761.750]
Pancreatic Diseases [C06.689]
Pancreatic Neoplasms [C06.689.667]
Carcinoma, Pancreatic Ductal [C06.689.667.625]
Endocrine System Diseases [C19]
Endocrine Gland Neoplasms [C19.344]
Pancreatic Neoplasms [C19.344.421]
Carcinoma, Pancreatic Ductal [C19.344.421.750]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Pancreatic Ductal".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Pancreatic Ductal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Pancreatic Ductal" by people in this website by year, and whether "Carcinoma, Pancreatic Ductal" was a major or minor topic of these publications.

Bar chart showing 32 publications over 12 distinct years, with a maximum of 6 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2011	1	0	1
2012	1	0	1
2013	4	0	4
2014	2	0	2
2015	3	0	3
2016	5	1	6
2017	1	0	1
2018	2	0	2
2019	2	0	2
2020	3	0	3
2023	5	0	5
2024	2	0	2

Below are the most recent publications written about "Carcinoma, Pancreatic Ductal" by people in Profiles.

Rodriguez VI, Mammadova J, Permuth JB, Luthra A, Pena L, Friedman M, Dam A, Cappelle S, Malafa MP, Hallmon C, Miranda C, Mok SRS. Elevated Urinary Levels of Fungal and Environmental Toxins in Patients with Pancreatic Ductal Adenocarcinoma. J Gastrointest Cancer. 2024 Oct 17; 56(1):4.

View in: PubMed
Sanchez P, Van Dyke AL, Petkov VI, Yuan Y, Bonds S, Valenzuela C, Tuan AW, Moravec R, Altekruse SF, Singhi AD, Serdy KM, Wu Y, Cress RD, Doherty JA, Mueller L, Hernandez BY, Lynch CF, Tucker TC, Wu XC, Matrisian L, Penberthy L. NCI SEER-Linked Virtual Tissue Repository Pilot. J Natl Cancer Inst Monogr. 2024 Aug 01; 2024(65):180-190.

View in: PubMed
Liou GY, Byrd CJ, Storz P, Messex JK. Cytokine CCL9 Mediates Oncogenic KRAS-Induced Pancreatic Acinar-to-Ductal Metaplasia by Promoting Reactive Oxygen Species and Metalloproteinases. Int J Mol Sci. 2024 Apr 26; 25(9).

View in: PubMed
Zhu J, Wu K, Liu S, Masca A, Zhong H, Yang T, Ghoneim DH, Surendran P, Liu T, Yao Q, Liu T, Fahle S, Butterworth A, Alam MA, Vadgama JV, Deng Y, Deng HW, Wu C, Wu Y, Wu L. Proteome-wide association study and functional validation identify novel protein markers for pancreatic ductal adenocarcinoma. Gigascience. 2024 01 02; 13.

View in: PubMed
Ingle K, LaComb JF, Graves LM, Baines AT, Bialkowska AB. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLoS One. 2023; 18(11):e0294065.

View in: PubMed
Zhong H, Liu S, Zhu J, Xu TH, Yu H, Wu L. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis. Int J Cancer. 2024 Mar 01; 154(5):852-862.

View in: PubMed
Liu S, Zhong H, Zhu J, Wu Y, Deng Y, Wu L. Regulome-wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk. Int J Cancer. 2024 Feb 15; 154(4):670-678.

View in: PubMed
Zhong H, Liu S, Zhu J, Wu L. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk. Int J Cancer. 2023 07 01; 153(1):103-110.

View in: PubMed
Telisnor G, DeRemer DL, Frimpong E, Agyare E, Allen J, Ricks-Santi L, Han B, George T, Rogers SC. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. J Natl Med Assoc. 2023 Apr; 115(2):164-174.

View in: PubMed
Ramakrishnan G, Parajuli P, Singh P, Friend C, Hurwitz E, Prunier C, Razzaque MS, Xu K, Atfi A. NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Cell Rep. 2022 11 08; 41(6):111623.

View in: PubMed

People

Explore

Similar Concepts

Top Journals